These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 5952861)

  • 41. [Experimental studies on the potency determination of typhoid vaccines. Part I. Protective effect of humoral antibodies of different specificity in the white mouse].
    HEYMANN G; JANDL G
    Z Immun exp ther; 1960 Mar; 119():279-94. PubMed ID: 14401642
    [No Abstract]   [Full Text] [Related]  

  • 42. Human cell mediated immunity to porins from Salmonella typhi.
    Blanco F; Isibasi A; Raúl González C; Ortiz V; Paniagua J; Arreguín C; Kumate J
    Scand J Infect Dis; 1993; 25(1):73-80. PubMed ID: 8384733
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The bactericidal action of typhoid antibody.
    NAGINGTON J
    Br J Exp Pathol; 1956 Aug; 37(4):385-96. PubMed ID: 13364149
    [No Abstract]   [Full Text] [Related]  

  • 44. [Disappearance rate from the circulation of normal & immune rabbits of typhoid vaccine labeled with P32 & injected by intravenous route].
    PAOLETTI A; BUONINCONTRO L
    Ann Sanita Pubblica; 1958; 19(5):1019-31. PubMed ID: 13606657
    [No Abstract]   [Full Text] [Related]  

  • 45. The role of epidemiology in the introduction of vi polysaccharide typhoid fever vaccines in Asia.
    Acosta CJ; Galindo CM; Ochiai RL; Danovaro-Holliday MC; Page AL; Thiem VD; Park JK; Park E; Koo H; Wang XY; Abu-Elyazeed R; Ali M; Albert MJ; Ivanoff B; Pang T; Xu ZY; Clemens JD
    J Health Popul Nutr; 2004 Sep; 22(3):240-5. PubMed ID: 15609776
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effectiveness of enteral immunization against typhoid fever with chemical Vi and O antigens.
    Pershin BB
    Fed Proc Transl Suppl; 1965; 24(6):1079-80. PubMed ID: 5321225
    [No Abstract]   [Full Text] [Related]  

  • 47. [The problem of control of antityphoid vaccines. IV. Experimental study of the immunogenic value of antityphoid vaccines tested by various methods].
    GABBRIELLI G; MORGANTETTI F
    Riv Ist Sieroter Ital; 1960; 35():498-504. PubMed ID: 13702758
    [No Abstract]   [Full Text] [Related]  

  • 48. Use of vaccines for the prevention of typhoid fever.
    Levine MM
    Indian Pediatr; 2003 Nov; 40(11):1029-34. PubMed ID: 14660833
    [No Abstract]   [Full Text] [Related]  

  • 49. Evaluation of phoP and rpoS mutants of Salmonella enterica serovar Typhi as attenuated typhoid vaccine candidates: virulence and protective immune responses in intranasally immunized mice.
    Lee HY; Cho SA; Lee IS; Park JH; Seok SH; Baek MW; Kim DJ; Lee SH; Hur SJ; Ban SJ; Lee YK; Han YK; Cho YK; Park JH
    FEMS Immunol Med Microbiol; 2007 Nov; 51(2):310-8. PubMed ID: 17725620
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Studies on immunity in experimental typhoid. 2. Mechanism of the clearance of bacteria in the peritoneal cavity of mice passively immunized with antiserum].
    AKIYAMA T; MAEDA K; USHIBA D
    Nihon Saikingaku Zasshi; 1962 Nov; 17():867-72. PubMed ID: 14011561
    [No Abstract]   [Full Text] [Related]  

  • 51. Oral typhoid vaccine.
    Hajee MA; Aleem
    J Assoc Physicians India; 1993 Jul; 41(7):471. PubMed ID: 8300504
    [No Abstract]   [Full Text] [Related]  

  • 52. A cluster-randomized effectiveness trial of Vi typhoid vaccine in India.
    Schwartz E
    N Engl J Med; 2009 Nov; 361(22):2191-2; author reply 2192-3. PubMed ID: 19950412
    [No Abstract]   [Full Text] [Related]  

  • 53. Comparison of two combined vaccines against typhoid fever and hepatitis A in healthy adults.
    Beeching NJ; Clarke PD; Kitchin NR; Pirmohamed J; Veitch K; Weber F
    Vaccine; 2004 Nov; 23(1):29-35. PubMed ID: 15519704
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Compatible concurrent administration of yellow fever 17D vaccine with oral, live, attenuated p6olera CVD103-HgR and typhoid ty21a vaccines.
    Tsai TF; Kollaritsch H; Que JU; Cropp CB; Kunz C; Wiedermann G; Herzog C; Cryz SJ
    J Infect Dis; 1999 Feb; 179(2):522-4. PubMed ID: 9878043
    [No Abstract]   [Full Text] [Related]  

  • 55. Salmonella typhi Vi antigen-negative isolates in India and prophylactic typhoid immunization.
    Arya SC
    Natl Med J India; 2000; 13(4):220. PubMed ID: 11002694
    [No Abstract]   [Full Text] [Related]  

  • 56. Immune responses to an oral typhoid vaccine strain that is modified to constitutively express Vi capsular polysaccharide.
    Tacket CO; Pasetti MF; Sztein MB; Livio S; Levine MM
    J Infect Dis; 2004 Aug; 190(3):565-70. PubMed ID: 15243933
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Doctor T. E. Woodward's legacy: from typhus to typhoid fever.
    Hornick RB; Woodward WE; Greisman SE
    Clin Infect Dis; 2007 Jul; 45 Suppl 1():S6-8. PubMed ID: 17582572
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antibody response to the protein antigens of "Salmonella typhi" during typhoid infection and following vaccination with a live oral typhoid vaccine Ty21a.
    Chau PY; Tsang RS
    Dev Biol Stand; 1983; 53():29-31. PubMed ID: 6873471
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Age for typhoid vaccination.
    John TJ
    Indian Pediatr; 1997 Jul; 34(7):649. PubMed ID: 9401263
    [No Abstract]   [Full Text] [Related]  

  • 60. Volunteer studies in the development of a live oral typhoid vaccine.
    Dima VF
    Arch Roum Pathol Exp Microbiol; 1983; 42(2-3):191-8. PubMed ID: 6673697
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.